Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Domain Therapeutics launches Mavalon with €9mm Series A round from Medicxi

Executive Summary

VC firm Medicxi invested €9mm ($9.9mm) to launch a new UK pharmaceutical company, Mavalon Therapeutics Ltd., formed to advance Domain Therapeutics SA's small-molecule G protein-coupled receptor (GPCR) pipeline in the area of Parkinson's disease.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Spin-Off
    • Venture Financing

Related Companies